WallStreetZenWallStreetZen

NASDAQ: CMAX
Caremax Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CMAX

Based on 2 analysts offering 12 month price targets for Caremax Inc.
Min Forecast
$6.40+99.38%
Avg Forecast
$33.20+934.27%
Max Forecast
$60.00+1,769.16%

Should I buy or sell CMAX stock?

Based on 2 analysts offering ratings for Caremax Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CMAX stock forecasts and price targets.

CMAX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2023-11-10

1 of 1

Forecast return on equity

Is CMAX forecast to generate an efficient return?

Forecast return on assets

Is CMAX forecast to generate an efficient return on assets?

CMAX revenue forecast

What is CMAX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$884.9M+17.81%
Avg 2 year Forecast
$994.6M+32.42%
Avg 3 year Forecast
$1.1B+49.78%
CMAX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CMAX revenue growth forecast

How is CMAX forecast to perform vs Health Information Services companies and vs the US market?
Company
14.22%
Industry
13.32%
Market
10.1%
CMAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CMAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CMAX vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
CMAX$3.21$33.20+934.27%Hold
ICCT$1.12N/AN/A
OTRK$0.30$4.00+1,246.80%Strong Buy
ONMD$0.61N/AN/A
ETAO$3.01N/AN/A
View Top Health Information Service Stocks

Caremax Stock Forecast FAQ

Is Caremax Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CMAX) stock is to Hold CMAX stock.

Out of 2 analysts, 0 (0%) are recommending CMAX as a Strong Buy, 0 (0%) are recommending CMAX as a Buy, 2 (100%) are recommending CMAX as a Hold, 0 (0%) are recommending CMAX as a Sell, and 0 (0%) are recommending CMAX as a Strong Sell.

If you're new to stock investing, here's how to buy Caremax stock.

What is CMAX's revenue growth forecast for 2024-2026?

(NASDAQ: CMAX) Caremax's forecast annual revenue growth rate of 14.22% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Caremax's revenue in 2024 is $751,102,000.On average, 2 Wall Street analysts forecast CMAX's revenue for 2024 to be $3,365,000,037, with the lowest CMAX revenue forecast at $3,317,673,158, and the highest CMAX revenue forecast at $3,412,326,916. On average, 2 Wall Street analysts forecast CMAX's revenue for 2025 to be $3,782,480,533, with the lowest CMAX revenue forecast at $3,768,542,967, and the highest CMAX revenue forecast at $3,796,418,099.

In 2026, CMAX is forecast to generate $4,278,243,375 in revenue, with the lowest revenue forecast at $4,278,243,375 and the highest revenue forecast at $4,278,243,375.

What is CMAX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CMAX) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of N/A.

What is CMAX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CMAX price target, the average CMAX price target is $33.20, with the highest CMAX stock price forecast at $60.00 and the lowest CMAX stock price forecast at $6.40.

On average, Wall Street analysts predict that Caremax's share price could reach $33.20 by Apr 1, 2025. The average Caremax stock price prediction forecasts a potential upside of 934.27% from the current CMAX share price of $3.21.

What is CMAX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CMAX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.